Renal Cancer - Results from #5040

Influence of microenvironment topography and stiffness on the mechanics and motility of normal and cancer renal cells August 9, 2017

Overexpression of long non-coding RNA differentiation antagonizing non-protein coding RNA inhibits the proliferation, migration and invasion and promotes apoptosis of renal cell carcinoma August 8, 2017

YRNA Expression Profiles are Altered in Clear Cell Renal Cell Carcinoma August 8, 2017

Understanding Mutational Drivers of Risk: An Important Step Toward Personalized Care for Patients with Renal Cell Carcinoma August 8, 2017

Full Modelling of High-Intensity Focused Ultrasound and Thermal Heating in the Kidney using Realistic Patient Models August 7, 2017

Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade August 7, 2017

Predictors of mortality in patients submitted to nephrectomy for non-metastatic renal cell carcinoma at a referral center in Northeastern Brazil August 6, 2017

Retroperitoneal Lymphadenectomy in High-Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial August 4, 2017

Metastatic renal cell carcinoma: Patterns and predictors of metastases-A contemporary population-based series August 4, 2017

Differentiation of renal cell carcinoma subtypes with different iodine quantification methods using single-phase contrast-enhanced dual-energy CT: areal vs. volumetric analyses August 4, 2017

Clear cell renal cell carcinoma: Validation of WHO/ISUP grading August 4, 2017

Laparoscopic Partial Nephrectomy with Sequential Precise Tumor-Specific Segmental Renal Artery Clamping for Multiple Ipsilateral Renal Tumors: a New Treatment Approach and Initial Experience August 3, 2017

Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma August 3, 2017

Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database August 3, 2017

Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice August 3, 2017

Real-world costs and outcomes in metastatic renal cell carcinoma patients treated by targeted therapies: a cohort study from the French health insurance database August 2, 2017

Components of metabolic syndrome and prognosis of renal cell cancer August 2, 2017

Systemic therapy following metastasectomy for renal cell carcinoma: Using insights from other clinical settings to address unanswered questions August 1, 2017

Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors August 1, 2017

Medication use and kidney cancer risk: A population-based study. July 31, 2017

Page 253 of 456